<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7196844\results\search\drug\results.xml">
  <result pre="treatment of chronic pancreatitis (4), but no clinical trials of" exact="camostat" post="in coronavirus infection have yet been conducted. Among the"/>
  <result pre="patientâ€™s cells (5). According to preliminary reports, the antimalarial drug" exact="chloroquine" post="prevents the terminal glycosylation of ACE2. Moreover, chloroquineâ€&quot;or its"/>
  <result pre="cell cultures, the replication of SARS-CoV-2 was inhibited at a" exact="chloroquine" post="concentration (EC50 = concentration with half-maximal effect) of 1.13"/>
  <result pre="Several clinical trials are investigating the efficacy and tolerability of" exact="chloroquine" post="in the prevention and treatment of COVID-19 (table 1)."/>
  <result pre="also not recommended for COVID-19 (9â€&quot; 11). The nucleoside analog" exact="ribavirin" post="was used at the beginning of the SARS epidemic"/>
  <result pre="is similar for the administration of some antiretrovirals, such as" exact="lopinavir" post="and nelfinavir, that were developed for the treatment of"/>
  <result pre="developed for the treatment of HIV infection. The protease inhibitor" exact="lopinavir" post="has been usedâ€&quot;together with a small booster dose of"/>
  <result pre="but yielded no clear evidence for the potential efficacy of" exact="lopinavir" post="(12). In Wuhan, 41 (21%) of 181 patients were"/>
  <result pre="hospital. The initial treatment was unspecific, with antipyretics such as" exact="ibuprofen" post="and paracetamol. Chest radiography then indicated pneumonia, upon which"/>
  <result pre="paracetamol. Chest radiography then indicated pneumonia, upon which the antibiotics" exact="vancomycin" post="and cefepime were given. They were discontinued a day"/>
  <result pre="radiography then indicated pneumonia, upon which the antibiotics vancomycin and" exact="cefepime" post="were given. They were discontinued a day later, however,"/>
  <result pre="Drugs are also available for acute viral infections. Treatment with" exact="aciclovir" post="can save the life of a patient with herpes"/>
  <result pre="the â€œnucleoside era,â€� in the 1970s, it was recognized that" exact="cytarabine" post="could not be used as a virustatic in disseminated"/>
  <result pre="&amp;gt;100 ÂµM. As shown in table 2, the nucleoside analog" exact="penciclovir" post="had a relatively weak effect (EC50: 96 ÂµM). Favipiravir,"/>
  <result pre="mechanisms and potential therapeutic targetIntensive Care Med2020 6WangMCaoRZhangLet al.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="in the United StatesN Engl J Med202038292993632004427 15StevensDAJordanGWWaddellTFMeriganTCAdverse effect of" exact="cytosine arabinoside" post="on disseminated zoster in a controlled trialN Engl J"/>
  <result pre="description of trial Number of participants Institution/sponsor Country Planned completion" exact="Chloroquine" post="Prevention, placebo-controlled trial (1:1 randomization)Participants: Employees in a health"/>
  <result pre="e.g., relatives of patients with COVID-19Treatment: Placebo or 10 mg" exact="chloroquine" post="base/kg, thereafter 250 mg chloroquine phosphate daily for 3"/>
  <result pre="COVID-19Treatment: Placebo or 10 mg chloroquine base/kg, thereafter 250 mg" exact="chloroquine" post="phosphate daily for 3 months 10 000 University of"/>
  <result pre="positive COVID-19 test resultTreatment: 800 mg darunavir (plus 150 mg" exact="cobicistat" post="as booster) for 7 days together with chloroquine; contacts"/>
  <result pre="for 7 days together with chloroquine; contacts receive 1 g" exact="chloroquine" post="phosphate on days 1 and 2, 0.5 g on"/>
  <result pre="Center Spain (Catalonia)Department of Health, Generalitat de Catalunya July 2020" exact="Hydroxychloroquine" post="Open trial, pilot studyParticipants: Patients with pneumonia from SARS-CoV-2Treatment:"/>
  <result pre="trial, pilot studyParticipants: Patients with pneumonia from SARS-CoV-2Treatment: 400 mg" exact="hydroxychloroquine" post="daily for 5 days 30 Shanghai Public Health Clinical"/>
  <result pre="mg/day for 2 weeks 400 Tongji Hospital China July 2020" exact="Thalidomide" post="Placebo-controlled double-blind trialParticipants: Patients with PCR-confirmed COVID-19 (max. 8"/>
  <result pre="since diagnosis); pulmonary findings on imagingTreatment: 1 Ã— 100 mg" exact="thalidomide" post="or placebo daily for 14 days 100 Second Affiliated"/>
  <result pre="substance to combat ebolaviruses, several clinical trials in COVID-19 0.77" exact="Chloroquine" post="4-Aminoquinoline derivative; prevention and treatment of malaria, also in"/>
  <result pre="action, clinical trials in influenza and other virus infections 2.1" exact="Nafamostat" post="Serine protease inhibitor, anticoagulant, inhibits membrane fusion, showed action"/>
  <result pre="clinical trials in influenza and other virus infections 2.1 Nafamostat" exact="Serine" post="protease inhibitor, anticoagulant, inhibits membrane fusion, showed action against"/>
  <result pre="membrane fusion, showed action against MERS-CoV in vitro 22 Favipiravir" exact="Pyrazine carboxamide," post="inhibits viral RNA-dependent RNA polymerase, licensed for treatment of"/>
  <result pre="RNA polymerase, licensed for treatment of influenza in Japan 62" exact="Penciclovir" post="Nucleoside analog, guanosine derivative, inhibits viral DNA polymerase; its"/>
  <result pre="Nucleoside analog, guanosine derivative, inhibits viral DNA polymerase; its prodrug" exact="famciclovir" post="is licensed for treatment of herpes zoster 96 Ribavirin"/>
  <result pre="prodrug famciclovir is licensed for treatment of herpes zoster 96" exact="Ribavirin" post="Nucleoside analog, guanosine derivative, inhibits inosine monophosphate dehydrogenase and"/>
 </snippets>
</snippetsTree>
